Overview
Evidence Prime is a company that builds software for the healthcare market, specifically tools for guideline developers and authors of systematic reviews. They offer an all-in-one web solution for summarizing and presenting information for healthcare decision-making, as well as pre-built software products and customization services for governmental and corporate clients. Their expertise includes software development, Natural Language Processing, and the GRADE methodology for evidence synthesis.
Financials
Revenue history (in k)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Industry
Bank accounts
Registered as a VAT taxpayer on 2017-05-22. Active
18 2490 0005 0000 4600 0034 5713- 39 2490 0005 0000 4600 0034 5723
- 95 2490 0005 0000 4600 0038 1963
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
Public aid
13 public aid cases recorded, with a total value of $6,214,760.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Oct 27, 2025 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $5,625$5,625 | Prezes Banku Gospodarstwa Krajowego | |
| Nov 26, 2024 | Aid for research and development projects: industrial research | $3.4M$3,397,128 | Prezes Polskiej Agencji Rozwoju Przedsiębiorczości | |
| Nov 26, 2024 | Aid for research and development projects: experimental development | $514.9K$514,904 | Prezes Polskiej Agencji Rozwoju Przedsiębiorczości |
European Funds
5 projects recorded: 2 from FE lists ($6,192,386) and 3 Commission grants (FTS) ($265,458).
| Start | Project | EU co-financing | Programme | |
|---|---|---|---|---|
| 2025-05-01 | European cancer information portal | $224.4K$224,436 | 1.0.11 - Horizon Europe | |
| 2025-05-01 | European cancer information portal | $26,347$26,347 | 1.0.11 - Horizon Europe | |
| 2025-05-01 | European cancer information portal | $14,675$14,675 | 1.0.11 - Horizon Europe |
Tenders
1 tender recorded as contractor.
| Publication date | Subject | Amount | Contracting authority | |
|---|---|---|---|---|
| Feb 21, 2024 | Systematic Review Tool Package - PR566982-3890-I | –– | Fraunhofer-Gesellschaft - Einkauf B12 |
Authorized Representatives
Manner of representation
In the case of a one-person management board, the member of the management board makes declarations on behalf of the company. In the case of a management board consisting of two or more persons, joint action by two members of the management board or by one member of the management board jointly with a commercial proxy is required to make declarations on behalf of the company.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Evidence Prime Incorporated | 100 | $1,350.62 | 100% |
Beneficial owners
| Person | Rights |
|---|---|
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| ODDKsp. z o.o. + limited partnership | $6,095,709.30 | oddk.pl | ||
| PMR Ltd.sp. z o.o. | $3,435,007.07 | pmrmarketexperts.com | ||
| Medplace.Plsp. z o.o. | $1,248,874.05 | medplace.pl | ||
| Medical Topicssp. z o.o. | $247,684.99 | medicaltopics.pl | ||
| Changeprosp. z o.o. | $208,311.29 | changepro.pl |
Change history
| Date | Event | |
|---|---|---|
| 2025-04-14 | Address change (Ul. Tadeusza Kościuszki 32, 30-105, Kraków → Ul. Tadeusza Kościuszki 32/1, 30-105, Kraków) | |
| 2025-02-20 | Address change (Ul. Toruńska 5, 30-056, Kraków → Ul. Tadeusza Kościuszki 32, 30-105, Kraków) | |
| 2025-02-20 | PKD change (Removed: 47, 58, 62, 62.01.Z, 63, 70, 72, 73, 74, 85; Added: 58.19.Z, 58.29.Z, 60.39.Z, 62.10.B, 62.20.A, 62.20.B, 62.90.Z, 63.92.Z, 71.20.C, 72.20.Z) | |
| 2017-05-08 | Entered in the register |
FAQ
Last updated: 2026-10-07